Education
About Us
Working with TipRanks
Follow Us
Selvita SA (PL:SLV)
:SLV
SLV Stock Chart & Stats
Day’s Range― - ―
52-Week Rangezł26.50 - zł62.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)40.37K
Market Cap
€679.15M
Enterprise ValueN/A
Total Cash (Recent Filing)€14.41M
Total Debt (Recent Filing)€204.42M
Price to Earnings (P/E)1434.1
Beta0.73
Next Earnings
Nov 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding18,355,474
10 Day Avg. Volume32,911
30 Day Avg. Volume40,372
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)2.82
Price to Sales (P/S)2.66
P/FCF Ratio20.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€40.03Price Target Upside8.19% Upside
Rating ConsensusHold
Number of Analyst Covering1
SLV FAQ
What was Selvita SA’s price range in the past 12 months?
Selvita SA lowest stock price was zł26.50 and its highest was zł62.40 in the past 12 months.
What is Selvita SA’s market cap?
Selvita SA’s market cap is €679.15M.
When is Selvita SA’s upcoming earnings report date?
Selvita SA’s upcoming earnings report date is Nov 20, 2025 which is in 45 days.
How were Selvita SA’s earnings last quarter?
Selvita SA released its earnings results on Sep 18, 2025. The company reported -zł0.251 earnings per share for the quarter, missing the consensus estimate of N/A by -zł0.251.
Is Selvita SA overvalued?
According to Wall Street analysts Selvita SA’s price is currently Undervalued.
Does Selvita SA pay dividends?
Selvita SA does not currently pay dividends.
What is Selvita SA’s EPS estimate?
Selvita SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Selvita SA have?
Selvita SA has 18,355,474 shares outstanding.
What happened to Selvita SA’s price movement after its last earnings report?
Selvita SA reported an EPS of -zł0.251 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 16.717%.
Which hedge fund is a major shareholder of Selvita SA?
Currently, no hedge funds are holding shares in PL:SLV
Company Description
Selvita SA
Selvita SA (SLV) is a biopharmaceutical company based in Poland that focuses on drug discovery and development, primarily targeting oncology and central nervous system (CNS) disorders. The company operates in the biotechnology sector, offering a range of services that include preclinical and clinical research for pharmaceutical companies. Selvita's core products and services encompass drug development programs, contract research services, and proprietary drug candidates, which are aimed at addressing unmet medical needs.
Technical Analysis
―
Ryvu Therapeutics SA
―
Celon Pharma SA
―
Captor Therapeutics SA
―
OncoArendi Therapeutics SA
―